Stephen Basso

Entity
Individual
Business address
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, 02210 Boston, MA
Signature Ownership
/s/ Stephen Basso
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Stephen Basso has filed 12 SEC EDGAR filings since 7/23/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Aug 22, 2025 Aug 20, 2025 000-30319
4 Open Document Open Filing OWNERSHIP DOCUMENT May 22, 2025 May 20, 2025 000-30319
4 Open Document Open Filing Mar 26, 2025 Feb 24, 2025 000-30319
4 Open Document Open Filing Feb 24, 2025 Feb 20, 2025 000-30319
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 7, 2024 Mar 5, 2024 000-30319
4 Open Document Open Filing OWNERSHIP DOCUMENT Aug 31, 2023 Aug 31, 2023 000-30319
3 Open Document Open Filing OWNERSHIP DOCUMENT Aug 31, 2023 Aug 21, 2023 000-30319
4 Open Document Open Filing FORM 4 SUBMISSION Mar 25, 2021 Mar 24, 2021 001-39397
4 Open Document Open Filing FORM 4 SUBMISSION Mar 17, 2021 Mar 4, 2021 001-39397
4 Open Document Open Filing FORM 4 SUBMISSION Jan 14, 2021 Jan 13, 2021 001-39397
4 Open Document Open Filing FORM 4 SUBMISSION Jul 24, 2020 Jul 23, 2020 001-39397
3 Open Document Open Filing FORM 3 SUBMISSION Jul 23, 2020 Jul 23, 2020 001-39397